Having no toxic debt, toxic notes, or dilution, more than enough to justify market cap.
We all could name plenty of otc stocks,
with higher o/s count, massive debt, dilution,
less or slightly more revenues trading higher
than .01
VitaCig is trading at these levels because
of a year long quiet period.
Not based on what revenues they have generated.
Case in point, the stock traded as high as
.08 following spin off, and between .03 -.05
early in the year.
With even less revenues!
We have already received revenue from out
global partners, so not sure why you expect
" a nice pile of revenue ".
VitaCig pre-relaunch, and VitaCig
post-relaunch, are two different companies.
The upcoming 10-Q represents VitaCig, in
a quiet period.
The company is no longer in a quiet period.
And is now focused on sales and revenues.
Expecting new product release this week,
and possibly a P.R. to go along with it.
Nice!
Go VTCQ$$$
News 
Market Data 
Discover 
